For patients with established atherosclerotic cardiovascular disease and overweight or obesity, the SELECT data support semaglutide 2.4 mg
While GLP-1 medications are not a 'quick fix,' they can be a powerful tool for regaining momentum, reducing health risks, and supporting long-term weight management goals
doi: 10.3390/cells10071775, Summary Keywords butyrate, carnitine, inulin, long-chain omega-3 fatty acids, nutraceuticals, obesity, pediatrics, vitamin B Citation Zuccotti G, Gatti A, Rossi V, Cordaro E and Calcaterra V (2026) Nutraceuticals for the management of weight and inflammation-related complications in obesity: a pediatric perspective
Figure 1 Collectively, these data show that acute liraglutide treatment significantly improves glucose tolerance, insulin sensitivity and impaired hepatic gluconeogenesis in SKO mice, with the greatest effects being observed in female SKO mice